Advanced search
Publication Cover
Cancer Investigation Volume 26, 2008 - Issue 3
Submit an article Journal homepage
137
Views
31
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

A Multicenter Cohort Study of Dose-Dense Temozolomide (21 of 28 Days) for the Treatment of Recurrent Anaplastic Astrocytoma or Oligoastrocytoma

Bart Neyns Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium
,
Cristo Chaskis Department of Neurosurgery, Universitair Ziekenhuis Brussel, Brussels, Belgium
,
Eric Joosens Medical Oncology, Ziekenhuis Network Middelheim, Antwerp, Belgium
,
Johan Menten Radiation-Oncology, Universitair Ziekenhuis Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium
,
Lionel D'Hondt Department of Hematology and Oncology, Centre Hospitalier Notre-Dame et Reine Fabiola, Charleroi, Belgium
,
Fabrice Branle Medical Oncology, Hopital Erasme, Université Libre de Bruxelles, Brussels, Belgium
,
Jan Sadones Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium
&
Alex Michotte Neuropathology/Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium
 show all
Pages 269-277 | Published online: 11 Jun 2009

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Rafael Roesler, André T Brunetto, Ana Lucia Abujamra, Caroline Brunetto de Farias, Algemir Lunardi Brunetto & Gilberto Schwartsmann. (2010) Current and emerging molecular targets in glioma. Expert Review of Anticancer Therapy 10:11, pages 1735-1751.
Read now
Margarita García, Ana Clopés, Jordi Bruna, María Martínez, Eduard Fort & Miguel Gil. (2009) Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations. Cancer Management and Research 1, pages 137-150.
Read now

Articles from other publishers (29)

Sumit Mukherjee, Angela Fried, Rahman Hussaini, Richard White, Juliet Baidoo, Sri Yalamanchi & Probal Banerjee. (2018) Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Catherine R. Garcia, Stacey A. Slone, Rachael M. Morgan, Lindsey Gruber, Sameera S. Kumar, Donita D. Lightner & John L. Villano. (2018) Dose-dense temozolomide for recurrent high-grade gliomas: a single-center retrospective study. Medical Oncology 35:10.
Crossref
Sumit Mukherjee, Juliet Baidoo, Samay Sampat, Andrew Mancuso, Lovena David, Leah Cohen, Shuiqin Zhou & Probal Banerjee. (2018) Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells. Molecules 23:1, pages 201.
Crossref
Wei Wei, Xin Chen, Ximeng Ma, Dawei Wang & Zongze Guo. (2015) The efficacy and safety of various dose-dense regimens of temozolomide for recurrent high-grade glioma: a systematic review with meta-analysis. Journal of Neuro-Oncology 125:2, pages 339-349.
Crossref
Motoo NAGANE. (2015) Dose-dense Temozolomide: Is It Still Promising?. Neurologia medico-chirurgica 55:1, pages 38-49.
Crossref
A. Benouaich-Amiel, I. Catalaa, V. Lubrano, E. Cohen-Jonathan Moyal & E. Uro-Coste. (2014) Glioma di alto grado: astrocitoma anaplastico e glioblastoma. EMC - Neurologia 14:3, pages 1-10.
Crossref
Norbert Galldiks, Theresa Berhorn, Tobias Blau, Veronika Dunkl, Gereon R. Fink & Michael Schroeter. (2013) “One week on–one week off”: efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center. Journal of Neuro-Oncology 112:2, pages 209-215.
Crossref
Filip Y. De Vos, Johanna M. Gijtenbeek, Chantal P. Bleeker-Rovers & Carla M. van Herpen. (2013) Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas. Critical Reviews in Oncology/Hematology 85:3, pages 373-382.
Crossref
Chao Chen, Tao Xu, Yicheng Lu, Juxiang Chen & Shenhong Wu. (2012) The efficacy of temozolomide for recurrent glioblastoma multiforme. European Journal of Neurology 20:2, pages 223-230.
Crossref
Claudia Scaringi, Vitaliana De Sanctis, Giuseppe Minniti & Riccardo Maurizi Enrici. (2013) Temozolomide-Related Hematologic Toxicity. Oncology Research and Treatment 36:7-8, pages 444-449.
Crossref
Herwig M. Strik, Christine Marosi, Bernd Kaina & Bart Neyns. (2012) Temozolomide Dosing Regimens for Glioma Patients. Current Neurology and Neuroscience Reports 12:3, pages 286-293.
Crossref
Walter Taal, Joyce M. W. Segers-van Rijn, Johan M. Kros, Irene van Heuvel, Carin C. D. van der Rijt, Jacoline E. Bromberg, Peter A. E. Sillevis Smitt & Martin J. van den Bent. (2012) Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study. Journal of Neuro-Oncology 108:1, pages 195-200.
Crossref
Annick Desjardins, David A. Reardon, April Coan, Jennifer Marcello, James E. HerndonIIII, Leighann Bailey, Katherine B. Peters, Henry S. Friedman & James J. Vredenburgh. (2011) Bevacizumab and daily temozolomide for recurrent glioblastoma. Cancer 118:5, pages 1302-1312.
Crossref
P. Gaviani, A. Silvani, E. Lamperti, A. Botturi, L. Fariselli, G. Simonetti, D. Ferrari & A. Salmaggi. (2011) Rechallenge with temozolomide in recurrent glioma. Neurological Sciences 32:S2, pages 247-249.
Crossref
Ufuk Abacioglu, Hale B. Caglar, Perran F. Yumuk, Zuleyha Akgun, Beste M. Atasoy & Meric Sengoz. (2010) Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma. Journal of Neuro-Oncology 103:3, pages 585-593.
Crossref
Matthias Holdhoff & Stuart A. Grossman. (2011) Controversies in the Adjuvant Therapy of High-Grade Gliomas. The Oncologist 16:3, pages 351-358.
Crossref
David A. Reardon, James J. Vredenburgh, Annick Desjardins, Katherine Peters, Sridharan Gururangan, John H. Sampson, Jennifer Marcello, James E. Herndon, Roger E. McLendon, Dorothea Janney, Allan H. Friedman, Darell D. Bigner & Henry S. Friedman. (2010) Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma. Journal of Neuro-Oncology 101:1, pages 57-66.
Crossref
Derek R. Johnson, Jonathan B. Ashman, Paul D. Brown, Daniel H. Lachance & Jan C. Buckner. 2011. Primary Central Nervous System Tumors. Primary Central Nervous System Tumors 103 141 .
Andrea Pace, Giulio Metro & Alessandra Fabi. (2010) Supportive care in neurooncology. Current Opinion in Oncology 22:6, pages 621-626.
Crossref
M. R. Gilbert, J. Gonzalez, K. Hunter, K. Hess, P. Giglio, E. Chang, V. Puduvalli, M. D. Groves, H. Colman, C. Conrad, V. Levin, S. Woo, A. Mahajan, J. de Groot & W. K. A. Yung. (2010) A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. Neuro-Oncology 12:11, pages 1167-1172.
Crossref
Kaisorn L. Chaichana, Thomas Kosztowski, Ashwini Niranjan, Alessandro Olivi, Jon D. Weingart, John Laterra, Henry Brem & Alfredo Quiñones-Hinojosa. (2010) Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults. Journal of Neurosurgery 113:2, pages 286-292.
Crossref
C G Robinson, J M Palomo, G Rahmathulla, M McGraw, J Donze, L Liu & M A Vogelbaum. (2010) Effect of alternative temozolomide schedules on glioblastoma O6-methylguanine-DNA methyltransferase activity and survival. British Journal of Cancer 103:4, pages 498-504.
Crossref
Bart Neyns, Alicia Tosoni, Wen‐Jen Hwu & David A. Reardon. (2010) Dose‐dense temozolomide regimens. Cancer 116:12, pages 2868-2877.
Crossref
A. Berrocal, P. Perez Segura, M. Gil, C. Balaña, J. Garcia Lopez, R. Yaya, J. Rodríguez, G. Reynes, O. Gallego & L. Iglesias. (2009) Extended-schedule dose-dense temozolomide in refractory gliomas. Journal of Neuro-Oncology 96:3, pages 417-422.
Crossref
Wolfgang Wick, Michael Platten & Michael Weller. (2009) New (alternative) temozolomide regimens for the treatment of glioma. Neuro-Oncology 11:1, pages 69-79.
Crossref
J. Sadones, A. Michotte, P. Veld, C. Chaskis, R. Sciot, J. Menten, E.J.R. Joossens, T. Strauven, L.A. D’Hondt, D. Sartenaer, S.F.E.H. Califice, K. Bierau, C. Svensson, J. De Grève & B. Neyns. (2009) MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. European Journal of Cancer 45:1, pages 146-153.
Crossref
Bart Neyns, Susanna Cordera, Eric Joosens & Pouratian Nader. (2008) Non-Hodgkin's Lymphoma in Patients With Glioma Treated With Temozolomide. Journal of Clinical Oncology 26:27, pages 4518-4519.
Crossref
Monika E. HegiLili LiuJames G. HermanRoger StuppWolfgang WickMichael WellerMinesh P. MehtaMark R. Gilbert. (2008) Correlation of O 6 -Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity . Journal of Clinical Oncology 26:25, pages 4189-4199.
Crossref
Clovis Orlando da Fonseca, Rafael Linden, Débora Futuro, Cerli Rocha Gattass & Thereza Quirico-Santos. (2008) Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol. Archivum Immunologiae et Therapiae Experimentalis 56:4, pages 267-276.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.